Pharming (PHAR) Interest Expenses (2020 - 2021)
Pharming (PHAR) reported Interest Expenses of -$5.24 million for Q4 2021, compared with -$12.99 million a year earlier.
Powered by 
Analysis
Pharming (PHAR) Interest Expenses (2020 - 2021) Analysis & Trends
For FY2021, Pharming posted Interest Expenses of $8,511.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.36 Bn | 1,105.95 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.62 Bn | 536.15 Bn | 17.26 Bn | 281.00 Mn |
| 3 | AbbVie | 501.17 Bn | 474.28 Bn | 12.70 Bn | - |
| 4 | Merck | 368.13 Bn | 322.51 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn | 462.00 Mn |
| 6 | Astrazeneca | 261.23 Bn | 234.92 Bn | 12.86 Bn | 435.00 Mn |
| 7 | Amgen | 236.68 Bn | 192.08 Bn | 7.24 Bn | 673.00 Mn |
| 8 | Gilead Sciences | 190.97 Bn | 165.17 Bn | 6.22 Bn | 247.00 Mn |
| 9 | Pfizer | 169.72 Bn | 116.36 Bn | 10.94 Bn | - |
| 10 | Pharming | 664.67 Mn | -129.70 Mn | 141.47 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2021 | -5.24 Mn |
| Mar 31, 2021 | 6.60 Mn |
| Dec 31, 2020 | -12.99 Mn |
API Access
Pharming Interest Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-expenses&ticker=PHAR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-expenses", "ticker": "PHAR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-expenses&ticker=PHAR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();